Amino Collective is an institutional venture capital firm in Berlin focused on early-stage health and bio companies. It invests primarily at pre-seed and seed, with transaction activity extending to Series A, and has acted as a lead investor at pre-seed. The firm backs HealthTech, biotechnology, life sciences, medical devices, pharmaceuticals and AI-enabled healthcare companies across the United Kingdom, broader Europe and the United States, making a select number of investments each year.